CA
NZ
UK
AU
IND
US
These warrants, originally issued with an exercise price of $2.60 and set to expire in 2025, were adjusted to a lower price of $1.35 per share. As part of this transaction, the company issued additional warrants for up to 6,601,632 shares of its common …
Ionis Pharmaceuticals (NASDAQ: IONS) announced its experimental drug eplontersen failed to achieve the primary goal in a late-stage study for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM). The CARDIO-TTRansform Phase 3 trial did not demonstrate a statistically significant benefit in reducing cardiovascular mortality or recurrent clinical events …
In the wake of Carasent AB's recent second-quarter earnings call, the healthcare sector is experiencing a pronounced ripple effect, with heightened investor interest and optimism about growth potential. Carasent AB's presentations highlighted positive developments that could bolster not only its own market standing but …
CervoMed Inc. (NASDAQ: CRVO) disclosed that its early‑stage clinical investigation of neflamapimod has reached full enrollment. The study targets patients with nonfluent variant primary progressive aphasia, a specific manifestation of frontotemporal dementia. The announcement marks a critical milestone in the firm’s development pipeline for …
ImmuCell Corporation (NASDAQ: ICCC) has reported a significant increase in product sales. The company announced an 11.5% increase in sales. This increase is a positive development for the healthcare company.
The latest filings for the 2027 Affordable Care Act (ACA) marketplace reveal a median premium increase of 14%, marking the second consecutive year of double‑digit hikes. Market participants anticipate that the larger premiums will lift health‑insurer revenue expectations while also weighing on enrollment trends …
Biohaven Ltd. (NYSE: BHVN) revealed a major leadership shift, with Bruce Car, Ph.D. Stepping down as Chief Scientific Officer. The change takes effect July 13, 2026, as part of a mutual agreement between Car and the biopharmaceutical company. Car will remain with Biohaven in …
Bone Biologics Corp (NASDAQ: BBLG), a clinical-stage orthobiologics company focused on bone regeneration, has successfully closed a private warrant offering to strengthen its financial position. The capital infusion will enable the company to accelerate its clinical programs while expanding its patent portfolio in the …
Brookdale Senior Living Inc. (NYSE: BKD) has provided investors with an operational snapshot for June 2026, marking its latest quarterly disclosure. The update focuses on occupancy trends and broader business conditions without releasing hard numbers.
60 DEGREES PHARMACEUTICALS, INC. Disclosed an update on its ongoing tafenoquine clinical trial targeting patients hospitalized with severe babesiosis (NCT 0627370). The filing outlines the statistical plan that will guide interim analyses and potential regulatory milestones.
Please wait processing your request...